CO: Global Cord Blood Corporation - Summary | Jitta

Global Cord Blood Corporation

NYSE:CO

Price
$4.03
Loss Chance
41.9%
5.61JITTA SCORE
60.17%Under Jitta Line
Jitta Ranking
7 / 1,123
222 / 4,767
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (66)
Recent Business Performance (49)
Financial Strength (88)
Return to Shareholders (27)
Competitive Advantage (53)
Jitta Signs
Revenue and EarningConsistent
Operating MarginExpansion
Debt LevelLow Long Term Debt
CapExVery Low
SG&A to SalesDecreasing
New Share IssuedMore than 50% in 5 years
Key Stats
Jitta Score
Jitta Line
5.61
60.17%
2.14
250.13%
Health Care Services
6.63
16.73%
5.98
18.57%
8.15
38.64%
COMPANY DESCRIPTION
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2021, it operated three cord blood banks in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.